Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic

NCT04263909 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04263909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04263909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2020
Completion date
December 30, 2023
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, pain, postoperative, spine fusion